Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region. [electronic resource]
- Cancer gene therapy Apr 2008
- 203-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5500
10.1038/sj.cgt.7701117 doi
Adenocarcinoma--pathology Adenovirus E1A Proteins--genetics Base Sequence Cell Line, Tumor DNA Primers Genetic Vectors Humans Male Promoter Regions, Genetic Prostatic Neoplasms--pathology